Indivior Pharmaceuticals, Inc. (INDV)
NASDAQ: INDV · Real-Time Price · USD
35.85
-0.74 (-2.02%)
At close: Sep 30, 2026, 4:00 PM EDT
35.55
-0.30 (-0.84%)
Pre-market: Oct 1, 2026, 5:47 AM EDT
Indivior Pharmaceuticals Market Cap
Indivior Pharmaceuticals has a market cap or net worth of $4.23 billion as of September 30, 2026. Its market cap has increased by 40.70% in one year.
Market Cap
4.23B
Enterprise Value
4.52B
1-Year Change
40.70%
Ranking
Category
Stock Price
$35.85
ChartMarket Cap Chart
Since December 29, 2014, Indivior Pharmaceuticals's market cap has increased from $1.53B to $4.23B, an increase of 176.42%. That is a compound annual growth rate of 9.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 4.23B | -5.56% |
| Dec 31, 2025 | 4.48B | 188.39% |
| Dec 31, 2024 | 1.55B | -25.50% |
| Dec 29, 2023 | 2.09B | -29.77% |
| Dec 29, 2022 | 2.97B | 22.55% |
| Dec 31, 2021 | 2.42B | 125.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Amneal Pharmaceuticals | 7.12B |
| Hims & Hers Health | 6.86B |
| Alkermes | 6.74B |
| Lantheus Holdings | 6.48B |
| Liquidia | 6.42B |
| Kiniksa Pharmaceuticals International, | 5.83B |
| Amylyx Pharmaceuticals | 3.67B |
| Regencell Bioscience Holdings | 3.09B |